Ambrx Biopharma, Inc.

GEODE CAPITAL MANAGEMENT, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

81,157

Value ($000)

1,156

Weight

0.0%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	1,156	0.0%	81,157	12/31/2023